WHO ICTRP trial
A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With…
JPRN-jRCT2080224809 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080224809 |
|---|---|
| Public title | A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD) [M15-741] |
| Scientific title | A 52-Week, Open-label, Single-arm Study to Evaluate the Safety and Tolerability of 24-hour Daily Exposure of Continuous Subcutaneous Infusion of ABBV-951 in Subjects With Parkinson's Disease [M15-741] |
| Primary sponsor | AbbVie G.K |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Japan;North America;Europe;Oceania |
| Conditions | Parkinson's Disease |
| Interventions | investigational material(s) Generic name etc : ABBV-951 INN of investigational material : - Therapeutic category code : 116 Antiperkinsonism agents Dosage and Administration for Investigational material : Continuous subcutaneous infusion… |
| Registration date | Jul 30, 2019 |
| Target size | 13 |
| Secondary IDs | NCT03781167;JapicCTI-194892 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: